Correspondence 0001213900-23-099517 from BiomX Inc. (PHGE)
BiomX Inc.
Date: Dec. 29, 2023 · CIK: 0001739174 · Accession: 0001213900-23-099517
AI Filing Summary & Sentiment
File numbers found in text: 333-275935
Show Raw Text
CORRESP
1
filename1.htm
BIOMX INC.
22 Einstein St., Floor 4
Ness Ziona, Israel 7414003
December 29, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: BiomX Inc. (CIK 0001739174)
Registration Statement on Form S-3 (File No. 333-275935)
(the “Registration Statement”)
Request for Acceleration of Effective Date
Dear Sir or Madam:
Pursuant to Rule 461 under
the Securities Act of 1933, as amended (the “Securities Act”), BiomX Inc. (the “Registrant”) hereby requests that
the effective date of the above-referenced Registration Statement be accelerated so that it will be declared effective on January 2, 2024
at 4:00 p.m., Eastern Time, or as soon as practicable thereafter.
The Registrant understands that
the Securities and Exchange Commission will consider this request for acceleration of the effective date of the Registration Statement
as a confirmation of the fact that the Registrant is aware of its responsibilities under the Securities Act as they relate to the proposed
public offering of the securities specified in the Registration Statement.
The Registrant respectfully requests
that it be notified of such effectiveness by a telephone call to Howard E. Berkenblit, Esq. of Sullivan & Worcester LLP at (617) 338-2979
and that such effectiveness also be confirmed in writing.
Very truly yours,
BiomX Inc.
By:
/s/ Avraham Gabay
Name:
Avraham Gabay
Title:
Interim Chief Financial Officer